Thymosin Beta 4 Bodybuilding Dosage: What the Evidence Says

Thymosin beta 4 bodybuilding dosage protocols usually run 4-5 mg per week for several weeks, but none are FDA-approved. Here's what research and users report.

ARTICLE OVERVIEW

Thymosin beta 4 bodybuilding dosage protocols usually run 4-5 mg per week for several weeks, but none are FDA-approved. Here's what research and users report.

The thymosin beta 4 bodybuilding dosage most often repeated online is 2 to 2.5 mg injected under the skin twice per week, for a weekly total of about 4 to 5 mg, run for four to six weeks and followed by roughly 2 mg per week as maintenance. Those numbers come from user reports and forum threads, not from controlled trials in athletes. Thymosin beta 4 is not approved by the FDA for human use in the United States, and no clinical trial has established a bodybuilding dosage for healthy people.

What Thymosin Beta 4 Is and Why Bodybuilders Discuss It

Thymosin beta 4 is a naturally occurring peptide made of 43 amino acids. It is found in nearly every human cell, where it helps regulate actin, cell migration, and tissue repair. The product sold online as TB-500 is a synthetic fragment of the same peptide, usually shipped as thymosin beta 4 acetate in a lyophilized powder that has to be reconstituted with bacteriostatic water.

Interest in bodybuilding circles traces back to animal studies showing faster healing of muscle, tendon, and skin injuries. Those studies used doses measured in milligrams per kilogram of body weight in rats and mice, and animal results do not translate directly into human dosing.

  • Not approved by the FDA for human use
  • Sold as a research chemical only
  • Banned by WADA in and out of competition

Commonly Reported Thymosin Beta 4 Bodybuilding Dosage

No official dosage guideline exists, so protocols vary widely between users. The table below summarizes the ranges that appear most often in public forum discussions.

Phase or ProtocolReported DoseFrequencyTypical Duration
Loading phase2-2.5 mgTwice weekly4-6 weeks
Maintenance phase1-2 mgOnce weekly4-8 weeks
Low-dose protocol1-1.5 mgTwice weekly2-4 weeks
Animal research dosing0.5-5 mg/kgStudy-dependentDays to weeks

Weekly totals in user reports generally land between 2 mg and 5 mg. Reported cycle lengths range from a few weeks to a few months, often with a break of similar length afterward. None of these schedules has been validated in a human clinical trial.

Why the Numbers Are Inconsistent

Doses vary because most users copy protocols from forums, and forum protocols are copied from each other. Vial labeling varies too, and under-dosed or mislabeled product is common in the gray market. A reported 2 mg dose may not contain 2 mg of active peptide.

How Users Typically Handle the Injection

Users usually describe a subcutaneous shot given with a small insulin syringe into abdominal fat. Some report intramuscular injections near a specific injury site, although no evidence shows that site-specific placement improves outcomes. Because no regulated thymosin beta 4 injection dosage exists, every published number is a user estimate rather than a medical standard.

Steps commonly described in forum write-ups include:

  1. Reconstituting the powder with bacteriostatic water.
  2. Refrigerating the vial after mixing.
  3. Swabbing the site and rotating injection locations.
  4. Recording dose and date to track a cycle.

Sterile technique matters because contaminated vials can cause infection. Sharing needles or multi-use vials carries additional risk.

What the Research Actually Shows

Peer-reviewed human research on thymosin beta 4 is limited and mostly focused on wound healing, corneal repair, and cardiac tissue after injury. Small studies have examined thymosin beta 4 eye drops for dry eye and corneal damage, and separate laboratory work has explored thymosin beta 4 hair growth through follicle stem cell activation. Nearly all of that research used the full-length peptide rather than the shorter TB-500 fragment.

Scientists also study the thymosin beta 4 fragment 17-23, a much smaller piece of the peptide with different activity in lab models. Findings from those experiments do not establish a bodybuilding protocol.

No human trial has shown that thymosin beta 4 builds muscle mass in healthy trainees. Claims about dramatic strength gains are not supported by controlled data.

Thymosin beta 4 is not approved by the FDA for human use in the United States. It is sold as a research chemical, which means vials are not inspected for sterility, potency, or identity by any regulator.

Side effects reported in user accounts include injection-site redness, swelling, headache, fatigue, and joint achiness. Serious risks include infection from non-sterile product, allergic reaction, and unknown long-term effects. Because thymosin beta 4 influences cell migration and actin regulation, theoretical concerns about unwanted cell growth exist, although human data are lacking.

WADA bans TB-500 at all times, so a positive test can cost an athlete eligibility. Anyone weighing a healing peptide for a real injury should consult a licensed healthcare professional instead of relying on forum advice.

Sourcing, Purity, and Reading Thymosin Beta 4 Reviews

Most thymosin beta 4 reviews published online are anecdotal and impossible to verify. Reviewers rarely post third-party lab tests, and a glowing review can be written by the seller.

When evaluating a vendor or a product, check for:

  • A certificate of analysis from an independent lab
  • Clear labeling of peptide content and purity percentage
  • Consistent batch numbers and expiration dates
  • Realistic claims — a seller promising guaranteed muscle growth is a red flag

Even a legitimate certificate does not make a research chemical safe or legal for human use. Purity data describe the powder inside the vial, not the safety of injecting it.

Frequently Asked Questions

What is the typical thymosin beta 4 bodybuilding dosage?

The most commonly repeated protocol is 2 to 2.5 mg injected subcutaneously twice per week, for a weekly total of about 4 to 5 mg, run for four to six weeks. A maintenance phase of roughly 1 to 2 mg once weekly sometimes follows. No clinical trial has validated any of these numbers, and thymosin beta 4 is not FDA-approved for human use.

Is thymosin beta 4 legal to buy in the United States?

Thymosin beta 4 is not a controlled substance under federal law, but it is also not FDA-approved for human use. Vials sold online are labeled as research chemicals intended for laboratory work only. Buying or possessing it for personal injection falls outside that labeling, and WADA bans TB-500 at all times.

Does thymosin beta 4 build muscle?

No controlled human study shows that thymosin beta 4 increases muscle mass or strength in healthy trainees. Animal research and small human trials have focused on wound healing, corneal repair, and tissue regeneration rather than hypertrophy. Users typically describe faster recovery from strains, not direct muscle growth.

Research information notice

This page provides educational research information and does not replace medical advice, diagnosis, or treatment.